Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Xu, Yaqin ^a   Tertilt, Christine ^a,b   Krause, Anja ^a   Quadri, Luis E N ^a   Crystal, Ronald G ^a   Worgall, Stefan ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; CAVEOLIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; CAV1 PROTEIN, MOUSE; LIPID; MESSENGER RNA; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION; LIPID METABOLISM; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; DNA MICROARRAY; GENETICS; GENOTYPE; LUNG; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE MARROW CELLS; CAVEOLIN 1; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DENDRITIC CELLS; DNA PRIMERS; FEMALE; GENOTYPE; LIPIDS; LUNG; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 68949135137     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-26     Document Type: Article

References (64)

1. Dean M. The genetics of ATP-binding cassette transporters. Methods in Enzymology Phase II Conjugation Enzymes and Transport Systems 2005, 400:409-429. Helmut Sies aLP. Academic Press.
2. Reddy MM, Quinton PM. Control of dynamic CFTR selectivity by glutamate and ATP in epithelial cells. Nature 2003, 423:756-760. 10.1038/nature01694, 12802335.
3. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073. 10.1126/science.2475911, 2475911.
4. Vergani P, Lockless SW, Nairn AC, Gadsby DC. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 2005, 433:876-880. 10.1038/nature03313, 15729345.
5. Boucher RC. An overview of the pathogenesis of cystic fibrosis lung disease. Advanced Drug Delivery Reviews 2002, 54:1359-1371. 10.1016/S0169-409X(02)00144-8, 12458149.
6. Gibson RL, Burns JL, Ramsey BW. 1Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003, 168:918-951. 10.1164/rccm.200304-505SO, 14555458.
7. Ratjen F, Doring G. Cystic fibrosis. The Lancet 2003, 361:681-689.
8. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996, 60:539-574. 239456, 8840786.
9. Rich DP, Anderson MP, Gregory RJ, Cheng SH, Paul S, Jefferson DM, McCann JD, Klinger KW, Smith AE, Welsh MJ. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990, 347:358-363. 10.1038/347358a0, 1699126.
10. Shen BQ, Finkbeiner WE, Wine JJ, Mrsny RJ, Widdicombe JH. Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion. Am J Physiol 1994, 266:L493-L501.
11. Assef YA, Damiano AE, Zotta E, Ibarra C, Kotsias BA. CFTR in K562 human leukemic cells. Am J Physiol Cell Physiol 2003, 285:C480-C488.
12. McDonald TV, Nghiem PT, Gardner P, Martens CL. Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current. Journal of Biological Chemistry 1992, 267:3242-3248.
13. Painter RG, Valentine VG, Lanson NA, Leidal K, Zhang Q, Lombard G, Thompson C, Viswanathan A, Nauseef WM, Wang G, et al. CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 2006, 45:10260-10269. 10.1021/bi060490t, 16922501.
14. Tousson A, Van Tine BA, Naren AP, Shaw GM, Schwiebert LM. Characterization of CFTR expression and chloride channel activity in human endothelia. Am J Physiol. 1998, 275(6 Pt1):C1555-C1564.
15. Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 2006, 8:933-944. 10.1038/ncb1456, 16921366.
16. Freedman SD, Weinstein D, Blanco PG, Martinez-Clark P, Urman S, Zaman M, Morrow JD, Alvarez JG. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid. J Appl Physiol 2002, 92:2169-2176.
17. Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, Tuck D, Krause DS, Egan ME. Macrophages directly contribute to the exaggerated inflammatory response in cftr-/-mice. American Journal of Respiratory Cell and Molecular Biology 2008,
18. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995, 152:2111-2118.
19. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151:1075-1082.
20. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004, 350:560-569. 10.1056/NEJMoa021218, 14762183.
21. Gentzsch M, Choudhury A, Chang X, Pagano RE, Riordan JR. Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. J Cell Sci 2007, 120:447-455. 10.1242/jcs.03350, 17213331.
22. Bhura-Bandali FN, Suh M, Man SFP, Clandinin MT. The ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr 2000, 130:2870-2875.
23. Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 2003, 9:322-330. 10.1038/nm823, 12563314.
24. Gulbins E, Dreschers S, Wilker B, Grassme H. Ceramide, membrane rafts and infections. Journal of Molecular Medicine 2004, 82:357-363. 10.1007/s00109-004-0539-y, 15069600.
25. Kowalski MP, Pier GB. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells Is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 2004, 172:418-425.
26. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annual Review of Immunology 2002, 20:621-667. 10.1146/annurev.immunol.20.100301.064828, 11861614.
27. Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunological Reviews 2007, 219:143-156. 10.1111/j.1600-065X.2007.00552.x, 17850487.
28. Moll H. Dendritic cells and host resistance to infection. Cellular Microbiology 2003, 5:493-500. 10.1046/j.1462-5822.2003.00291.x, 12864809.
29. Moll H. Antigen delivery by dendritic cells. International Journal of Medical Microbiology 2004, 294:337-344. 10.1016/j.ijmm.2004.03.003, 15532992.
30. Bist A, Fielding CJ, Fielding PE. p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry 2000, 39:1966-1972. 10.1021/bi991721h, 10684646.
31. Bist A, Fielding PE, Fielding CJ. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proceedings of the National Academy of Sciences 1997, 94:10693-10698.
32. Czarny M, Fiucci G, Lavie Y, Banno Y, Nozawa Y, Liscovitch M. Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains. FEBS Letters 2000, 467:326-332. 10.1016/S0014-5793(00)01174-1, 10675563.
33. Ferno J, Skrede S, Vik-Mo A, Havik B, Steen V. Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: Marked differences between various antipsychotic drugs. BMC Neuroscience 2006, 7:69. 1635424, 17052361, 10.1186/1471-2202-7-69.
34. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131. 150968, 11994399.
35. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proceedings of the National Academy of Sciences 2003, 100:12027-12032.
36. Kim JH, Lee JN, Paik YK. Cholesterol biosynthesis from lanosterol. a concerted role for Sp1 and NF-Y-binding sites for sterol-mediated regulation of rat 7-dehydrocholesterol reductase gene expression. Journal of Biological Chemistry 2001, 276:18153-18160. 10.1074/jbc.M101661200, 11279217.
37. Tabor DE, Kim JB, Spiegelman BM, Edwards PA. Transcriptional activation of the Stearoyl-CoA Desaturase 2 gene by sterol regulatory element-binding protein/adipocyte determination and differentiation factor 1. Journal of Biological Chemistry 1998, 273:22052-22058. 10.1074/jbc.273.34.22052, 9705348.
38. Worgall S, Martushova K, Busch A, Lande L, Crystal RG. Apoptosis induced by Pseudomonas aeruginosa in antigen presenting cells is diminished by genetic modification with CD40 ligand. Pediatr Res 2002, 52:636-644.
39. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics International 2004, 11:36-42.
40. Koller BH, Kim H, Latour AM, Brigman K, Boucher RC, Scambler P, Wainwright B, Smithies O. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proceedings of the National Academy of Sciences 1991, 88:10730-10734.
41. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O. An animal model for cystic fibrosis made by gene targeting. Science 1992, 257:1083-1088. 10.1126/science.257.5073.1083, 1380723.
42. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Progress in Lipid Research 2001, 40:439-452. 10.1016/S0163-7827(01)00010-8, 11591434.
43. Hazlett LD, McClellan SA, Rudner XL, Barrett RP. The role of langerhans cells in Pseu-domonas aeruginosa infection. Invest Ophthalmol Vis Sci 2002, 43:189-197.
44. Guilbault C, Novak JP, Martin P, Boghdady ML, Saeed Z, Guiot MC, Hudson TJ, Radzioch D. Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls. Physiol Genomics 2006, 25:179-193. 10.1152/physiolgenomics.00206.2005, 16418321.
45. Kaur S, Norkina O, Ziemer D, Samuelson LC, De Lisle RC. Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. Am J Physiol Gastrointest Liver Physiol 2004, 287:G480-G490. 10.1152/ajpgi.00035.2004, 15064229.
46. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004, 286:G1032-G1041. 10.1152/ajpgi.00473.2003, 14739145.
47. Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, Wooldridge JL, Whitsett JA. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 2003, 278:7674-7682. 10.1074/jbc.M210277200, 12482874.
48. Xu Y, Liu C, Clark JC, Whitsett JA. Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTRΔ508 in the lung. Journal of Biological Chemistry 2006, 281:11279-11291. 10.1074/jbc.M512072200, 16455659.
49. Xu Z, Gupta V, Lei D, Holmes A, Carlson EJ, Gruenert DC. In-frame elimination of exon 10 in Cftrtm1Unc CF mice. Gene 1998, 211:117-123. 10.1016/S0378-1119(98)00090-0, 9573345.
50. Ostrowski LE, Yin W, Diggs PS, Rogers TD, O'Neal WK, Grubb BR. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice. Gene Ther 2007, 14:1492-1501. 10.1038/sj.gt.3302994, 17637798.
51. Borthwick DW, West JD, Keighren MA, Flockhart JH, Innes BA, Dorin JR. Murine submucosal glands are clonally derived and show a cystic fibrosis gene-dependent distribution pattern. Am J Respir Cell Mol Biol 1999, 20:1181-1189.
52. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, Davis PB. CFTR inhibition mimics the cystic fibrosis inflammatory profile. American Journal of Physiol Lung Cell Mol Physiol 2007, 292:L383-l393.
53. Anderson RGW. The caveolae membrane system. Annual Review of Biochemistry 1998, 67:199-225. 10.1146/annurev.biochem.67.1.199, 9759488.
54. Liu P, Rudick M, Anderson RGW. Multiple functions of caveolin-1. J Biol Chem 2002, 277:41295-41298. 10.1074/jbc.R200020200, 12189159.
55. White NM, Jiang D, Burgess JD, Bederman IR, Previs SF, Kelley TJ. Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2007, 292:L476-L486. 10.1152/ajplung.00262.2006, 17085523.
56. Reiniger N, Ichikawa JK, Pier GB. Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells. Infect Immun 2005, 73:6822-6830. 1230967, 16177360, 10.1128/IAI.73.10.6822-6830.2005.
57. Tiruppathi C, Shimizu J, Miyawaki-Shimizu K, Vogel SM, Bair AM, Minshall RD, Predescu D, Malik AB. Role of NF-kappaB-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide. J Biol Chem 2008, 283:4210-4218. 2435298, 18077459, 10.1074/jbc.M703153200.
58. Nowaczyk MJ, Waye JS, Douketis JD. DHCR7 mutation carrier rates and prevalence of the RSH/Smith-Lemli-Opitz syndrome: where are the patients?. Am J Med Genet A 2006, 140:2057-2062.
59. Yu H, Patel SB. Recent insights into the Smith-Lemli-Opitz syndrome. Clin Genet 2005, 68:383-391. 1350989, 16207203, 10.1111/j.1399-0004.2005.00515.x.
60. Miyazaki M, Ntambi JM. Role of stearoyl-coenzyme A desaturase in lipid metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids 2003, 68:113-121.
61. Kirschnek S, Gulbins E. Phospholipase A2 functions in Pseudomonas aeruginosa- induced apoptosis. Infection and Immunity 2006, 74:850-860.
62. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, Goldstein JL. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 1996, 15:1012-1020. 449996, 8605870.
63. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005, 171(11):1209-1223. 10.1164/rccm.200408-1044SO, 15695491.
64. Puri V, Jefferson JR, Singh RD, Wheatley CL, Marks DL, Pagano RE. Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage. Journal of Biological Chemistry 2003, 278:20961-20970. 10.1074/jbc.M300304200, 12657626.